Russia's Sputnik Light vaccine shows 70% effectiveness against Delta variant of COVID-19 during the first three months after vaccination, the Russian Direct Investment Fund (RDIF) said citing data from the vaccine's developer. It is 75% effective among subjects under the age of 60, RDIF added. The data was based on 28,000 participants and an unvaccinated control group of 5.6 million.